John M. Finke

Antibody concentrations to Aβ1–42 monomer and soluble oligomers in untreated and antibody–antigen-dissociated intravenous immunoglobulin preparations

Andrea C. Klaver, John M. Finke, Jyothi L. Digambaranath et al. · International Immunopharmacology · 2009 · 48 citations

Allergy, Medicine, Soluble Oligomers +10

Measurement of anti-Aβ1–42 antibodies in intravenous immunoglobulin with indirect ELISA: The problem of nonspecific binding

Andrea C. Klaver, Lynnae M. Patrias, Mary P. Coffey et al. · Journal of Neuroscience Methods · 2010 · 34 citations

Allergy, Autoimmune Disease, Intravenous Immunoglobulin +13

Specificity and sensitivity of the Abeta oligomer ELISA

Andrea C. Klaver, Lynnae M. Patrias, John M. Finke et al. · Journal of Neuroscience Methods · 2010 · 32 citations

Immunocytochemical Technique, Allergy, Autoimmune Disease +7

ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

Andrea C. Klaver, Mary P. Coffey, Lynnae M. Smith et al. · Journal of Neuroinflammation · 2011 · 26 citations · Full text

Antibody blood-brain barrier efflux is modulated by glycan modification

John M. Finke, Kari R. Ayres, Ryan Brisbin et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2017 · 20 citations · Full text

Glycan Modification, Blood–brain Barrier, Medicine +6